Scholarly publications and presentations by Rochester Regional Health's Allergy and Immunology department authors.
Submissions from 2023
12-1-2023 Drug Allergy in Women, Erika Yue Lee, Division of Clinical Immunology and Allergy, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Eliot Phillipson Clinician-Scientist Training Program, University of Toronto, Toronto, Ontario, Canada., Ana Maria Copaescu, Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada; Research Institute of McGill University Health Centre, McGill University, McGill University Health Centre, Montreal, Quebec, Canada; Department of Medicine, Austin Health, University of Melbourne, Heidelberg, Victoria, Australia., Jason A. Trubiano, Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia; Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia., et al.
12-1-2023 The promise and power of patient partnerships and advocacy, Karen S. Blatman, Section of Allergy and Clinical Immunology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire; Geisel School of Medicine at Dartmouth, Hanover, New Hampshire., Peter Capucilli, Rochester Regional Health, Alexandra Conway, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire., et al.
12-1-2023 United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions, David A. Khan, Department of Internal Medicine, Division of Allergy and Immunology, University of Texas Southwestern Medical Center, Dallas, Tex., Elizabeth J. Phillips, Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tenn; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tenn., John J. Accarino, Department of Medicine, Division of Rheumatology, Allergy and Immunology, Boston, Mass; Harvard Medical School, Boston, Mass., et al.
12-1-2023 Women's Health in Allergy/Immunology and Women in Allergy/Immunology, Allison Ramsey, Rochester Regional Health and Jennifer Namazy, Adult and Pediatric Allergy and Immunology, Scripps Clinic, San Diego, Calif.
11-30-2023 Drug Allergy Update, Allison Ramsey, Rochester Regional Health
11-1-2023 COVID-19 Treatments: Then and Now, S Shahzad Mustafa, Rochester Regional Health, Rebecca A. Stern, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Pratish C. Patel, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., et al.
11-1-2023 Drug allergy in older adults: A study from the United States Drug Allergy Registry, John J. Accarino, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts., Allison Ramsey, Rochester Regional Health, Upeka Samarakoon, Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., et al.
11-1-2023 Outcomes of oral food challenges in a real-world setting, with predictors of outcomes, S Shahzad Mustafa, Rochester Regional Health, Jonathan Bress, Rochester Regional Health, Peter Capucilli, Rochester Regional Health, et al.
10-1-2023 Direct challenges are the gold standard for most antibiotic allergy evaluations, Allison Ramsey, Rochester Regional Health; Cheryl Rozario, Department of Medicine, University of Rochester, Rochester, New York.; and Jessica Stern, Department of Medicine, University of Rochester, Rochester, New York.
10-1-2023 Recommendations for Management of Secondary Antibody Deficiency in Multiple Myeloma, Sergio Giralt, Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Stephen Jolles, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Tessa Kerre, Department of Hematology, Ghent University Hospital, Ghent, Belgium., et al.
9-1-2023 Achenbach Syndrome in a Patient with Raynaud's Phenomenon, Massiel E. Jimenez, Rochester Regional Health and Anthony Ocon, Rochester Regional Health
9-1-2023 Immune response evolution in peanut epicutaneous immunotherapy for peanut-allergic children, Marie Bastin, DNAlytics, Ottignies-Louvain-la-Neuve, Belgium., Warner W. Carr, Allergy and Asthma Associates of Southern California, Southern California Research, California, Mission Viejo, USA., Carla M. Davis, Department of Pediatrics, Immunology, Allergy, and Retrovirology Division, Baylor College of Medicine, Houston, Texas, USA., et al.
9-1-2023 The Penicillin Allergy Decision Rule-Something New for Penicillin Allergy, Allison Ramsey, Rochester Regional Health and S Shahzad Mustafa, Rochester Regional Health
8-1-2023 Treating Common Variable Immunodeficiency With Subcutaneous Immunoglobulin: A Challenge With Several Social Determinants of Health, Roshan Subedi, Rochester Regional Health; S Shahzad Mustafa, Rochester Regional Health; and Allison Ramsey, Rochester Regional Health
8-1-2023 Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach, Matthew Greenhawt, Timothy E Dribin, Elissa M Abrams, et al.
6-1-2023 Chronic Anti-HMG-CoA Reductase Positive Necrotizing Myositis With Remote Exposure to Statins, Tooba Salar, Rochester Regional Health, Massiel Jimenez, Rochester Regional Health, Mazin Hameed, Rochester Regional Health, et al.
6-1-2023 Steroid-induced secondary immune deficiency, S Shahzad Mustafa, Rochester Regional Health
5-11-2023 Updates in Asthma, Sara Patrawala, Rochester Regional Health
5-1-2023 The need for change: Lessons learned from Food and Drug Administration-approved peanut oral immunotherapy, S Shahzad Mustafa, Rochester Regional Health and Douglas P. Mack, McMaster University, Hamilton, Ontario, Canada.
4-1-2023 Food allergy and travel: Is it time to establish best practice parameters?, Irene Yuan, Vanderbilt University Medical Center, Nashville, Tennessee. and Peter Capucilli, Rochester Regional Health
3-1-2023 Real-World Experience of Tixagevimab and Cilgavimab (Evusheld) in Rheumatologic Patients on Rituximab, Anthony J. Ocon, Rochester Regional Health and S. Shahzad Mustafa, Rochester Regional Health
3-2023 Secondary antibody deficiency in chronic lymphocytic leukemia and non-Hodgkin lymphoma: Recommendations from an international expert panel, Stephen Jolles, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Sergio Giralt, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Tessa Kerre, Faculty of Medicine and Health Sciences, Ghent University Hospital, Ghent, Belgium., et al.
2-15-2023 Structure and IgE Cross-Reactivity among Cashew, Pistachio, Walnut, and Peanut Vicilin-Buried Peptides, Alexander C. Foo, Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, 111 T.W. Alexander Drive, MD-MR01, Durham, North Carolina 27709, United States., Jacqueline B. Nesbit, Agricultural Research Service, United States Department of Agriculture, 1100 Allen Toussaint Boulevard, New Orleans, Louisiana 70124, United States., Stephen A. Gipson, Agricultural Research Service, United States Department of Agriculture, 1100 Allen Toussaint Boulevard, New Orleans, Louisiana 70124, United States., et al.
2-7-2023 Agents contributing to secondary immunodeficiency development in patients with multiple myeloma, chronic lymphocytic leukemia and non-Hodgkin lymphoma: A systematic literature review, Stephen Jolles, Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Sergio Giralt, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, United States., Tessa Kerre, Faculty of Medicine and Health Sciences, Ghent University Hospital, Ghent, Belgium., et al.
2-1-2023 A Randomized Trial of Penicillin Skin Testing Versus 2-Step Direct Challenge for Penicillin Allergy During Pregnancy, Allison Ramsey, Rochester Regional Health and S. Shahzad Mustafa, Rochester Regional Health